11,724 Radiation Therapy Procedures and 1,300 Nuclear Medicine Scans

Makkah – Corporate Communications

Dr. Adel bin Abdulqader Tash, Chief Executive Officer of King Abdullah Medical City, a member of the Makkah Health Cluster, inaugurated a new linear accelerator and several advanced treatment technologies at the Jeddah Oncology Center. This strategic step enhances the quality of specialized care provided to cancer patients and supports the Medical City's commitment to adopting the latest global technologies to improve treatment accuracy, clinical outcomes, and beneficiary experience.

King Abdullah Medical City stated that the Jeddah Oncology Center continues to reinforce its position as one of the leading specialized oncology referral centers in Saudi Arabia and the Western Region. The center serves a large number of patients referred from various regions and healthcare organizations through an integrated system supported by more than 100 medical, technical, and administrative specialists.

The Medical City further reported continuous growth in the center’s therapeutic and diagnostic services. During 2025, the center performed 11,724 radiation therapy procedures and 1,300 nuclear medicine scans, reflecting the ongoing expansion of specialized services and the increasing efficiency of patient care.

The new linear accelerator represents a significant enhancement to the center’s treatment capabilities. It enables highly precise delivery of radiation doses directly to tumors while preserving surrounding healthy tissues, reducing potential side effects, improving treatment effectiveness, and shortening treatment session durations, ultimately enhancing patient safety and healthcare outcomes.

In addition, the center has strengthened its technological infrastructure with a range of advanced intelligent systems, including Mobius3D, which improves treatment planning accuracy and provides independent radiation dose verification to ensure the highest standards of safety and quality. The center has also implemented the IDENTIFY system, which enables real-time monitoring of patient movement during treatment sessions, further improving treatment precision.

The Medical City also highlighted the introduction of advanced HyperArc and RapidArc Dynamic technologies, which provide highly precise solutions for treating brain tumors and other complex cancers. These technologies enhance dose delivery efficiency, reduce treatment session times, and minimize radiation exposure to healthy tissues and nearby sensitive organs.

The Medical City noted significant growth in nuclear medicine services over recent years. The average annual number of scans increased from approximately 800 scans in 2021 to 1,300 scans in 2025, while the number of radioactive isotope therapy cases rose from 18 cases to 43 cases during the same period. These advancements contribute to more accurate diagnoses and more effective treatment plans for patients.

King Abdullah Medical City emphasized that these projects and technologies are part of a comprehensive strategy aimed at advancing clinical excellence, driving healthcare innovation, expanding access to highly specialized services, and adopting the latest global treatment technologies. These efforts align with the objectives of Saudi Arabia’s Health Sector Transformation Program and further strengthen the Medical City's position as a leading national and regional reference center for oncology care and advanced specialized healthcare.

The Medical City reaffirmed its commitment to investing in medical expertise, advanced technologies, and scientific research to deliver specialized healthcare in accordance with international best practices, enhance quality of life, and improve treatment outcomes for cancer patients.